DrugPipeline.net has announced the addition of “Australia Market Report for Peripherally Inserted Central Catheters 2017 - MedCore” research report to their website DrugPipeline.net
Bangalore, Karnataka -- (SBWIRE) -- 02/23/2017 -- General Report Contents
- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions
The adoption of PICCs significantly increased following the increasing use of ultrasound to provide guidance in catheter placement. Emerging technology such as tip navigation will further aid in ensuring patient safety and is expected to bolster the demand for PICCs. A major factor driving growth in the PICC market is the reduction in overall procedure cost associated with PICC implantation. This reduction is mainly due to the fact that nurses are able to place PICCs instead of physicians, and the implantation does not require an operating suite as is the case with an implantable port. The prices for PICCs have been negatively impacted by aggressive price cuts from leading companies in response to public tenders. A significant disparity in the price of different products existed in the past years as companies were still able to differentiate their product by offering education and training to practitioners. This trend has reversed and ASPs are projected to decline over the forecast period.
The Australian market for peripherally inserted central catheters (PICCs) is split up into two segments: power-injectable and non-power-injectable PICCs. Non-power-injectable PICCs are defined as PICCs that do not feature power-injection or antimicrobial properties. Power-injectable PICCs have become the standard of care in Australia and in the United States, whereas Japan still prefers conventional PICCs. In 2016, power-injectable PICCs represented less than 70% of the total market for PICCs, with the remaining balance represented by non-power-injectable PICCs. Growth in the unit sales of advanced materials PICCs is expected to drive gains in the share of power-injectable PICCs over the forecast period.
Spanning over 436 pages "Australia Market Report for Peripherally Inserted Central Catheters 2017 - MedCore" report covers Executive Summary, Australia Vascular Access Device And Accessories Market Overview, Competitive Analysis, Market Trends, Research Methodology, Disease Overview, Product Assessment, Peripherally Inserted Central Catheter Market, Appendix. The report covered companies are - C. R. Bard, Becton Dickinson, Teleflex, Smiths Medical, B. Braun, Cook Medical, Medcomp, Angiodynamics, Medtronic, Baxter
For more information Visit at: http://www.drugpipeline.net/idata-research/australia-market-report-peripherally-inserted-central-catheters-2017-medcore
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.